JP2020514369A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020514369A5 JP2020514369A5 JP2019550787A JP2019550787A JP2020514369A5 JP 2020514369 A5 JP2020514369 A5 JP 2020514369A5 JP 2019550787 A JP2019550787 A JP 2019550787A JP 2019550787 A JP2019550787 A JP 2019550787A JP 2020514369 A5 JP2020514369 A5 JP 2020514369A5
- Authority
- JP
- Japan
- Prior art keywords
- loxl2
- antibody
- kit
- cancer
- immunoassay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1704206.0 | 2017-03-16 | ||
| GBGB1704206.0A GB201704206D0 (en) | 2017-03-16 | 2017-03-16 | Lysyl oxidase like-2 assay |
| PCT/EP2018/056364 WO2018167132A1 (en) | 2017-03-16 | 2018-03-14 | Lysyl oxidase like-2 assay |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020514369A JP2020514369A (ja) | 2020-05-21 |
| JP2020514369A5 true JP2020514369A5 (enExample) | 2021-04-22 |
Family
ID=58688361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019550787A Pending JP2020514369A (ja) | 2017-03-16 | 2018-03-14 | リシルオキシダーゼ様２アッセイ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20200123272A1 (enExample) |
| EP (1) | EP3596127A1 (enExample) |
| JP (1) | JP2020514369A (enExample) |
| GB (1) | GB201704206D0 (enExample) |
| WO (1) | WO2018167132A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12578335B2 (en) | 2020-02-05 | 2026-03-17 | Syntara Limited | Bioprobes for lysyl oxidases and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012019693A2 (pt) * | 2010-02-04 | 2017-06-20 | Gilead Biologics Inc | anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles. |
| AP2013007285A0 (en) * | 2011-06-01 | 2013-11-30 | Gilead Biologics Inc | Lysyl oxidase-like 2 assay and methods of use thereof |
| MX2015005448A (es) * | 2012-10-30 | 2015-11-06 | Gilead Sciences Inc | Metodos de terapia y diagnostico relacionados con lisil oxidasa-tipo 2 (loxl2). |
-
2017
- 2017-03-16 GB GBGB1704206.0A patent/GB201704206D0/en not_active Ceased
-
2018
- 2018-03-14 JP JP2019550787A patent/JP2020514369A/ja active Pending
- 2018-03-14 EP EP18713814.4A patent/EP3596127A1/en not_active Withdrawn
- 2018-03-14 US US16/494,472 patent/US20200123272A1/en not_active Abandoned
- 2018-03-14 WO PCT/EP2018/056364 patent/WO2018167132A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ferreira et al. | DNA aptamers against the MUC1 tumour marker: design of aptamer–antibody sandwich ELISA for the early diagnosis of epithelial tumours | |
| CN103703370B (zh) | 诊断性肽的检测 | |
| JP2018042573A5 (enExample) | ||
| JP7022191B2 (ja) | 前立腺がんの分析のための組成物及び方法 | |
| JP6307509B2 (ja) | 腎機能の診断若しくは監視又は腎機能障害の診断方法 | |
| JP2013533977A5 (enExample) | ||
| JP2015533788A5 (enExample) | ||
| US20230184787A1 (en) | Calprotectin Assay | |
| JP2014518624A5 (enExample) | ||
| JP2015514707A5 (enExample) | ||
| JP2020514369A5 (enExample) | ||
| Hong et al. | Development of a novel ssDNA aptamer targeting neutrophil gelatinase-associated lipocalin and its application in clinical trials | |
| DK2904398T3 (en) | Procedures for predicting the risk of getting cancer in a female individual | |
| JP2020514368A5 (enExample) | ||
| JP2022031783A (ja) | ＡＰＰ６６９－ｘのＮ末端を特異的に認識する抗体、及び免疫測定法 | |
| JP6317763B2 (ja) | 対象における癌となる危険性を予測し又は癌と診断する方法 | |
| JP2012521745A5 (enExample) | ||
| JP2012504408A5 (enExample) | ||
| CA3169588A1 (en) | Biomarker, methods, and compositions thereof for evaluation or management of kidney function or diagnosing or aid in diagnosing kidney dysfunction or kidney disease | |
| JP2015075395A (ja) | 抗ＮＭＤＡＲ抗体の各ＩｇＧサブクラスの濃度の定量方法 | |
| JPWO2019217684A5 (enExample) | ||
| Tang et al. | Development and validation of a magnetic nanoparticle-based chemiluminescent immunoassay for serum surfactant protein D in pulmonary diseases | |
| Guo et al. | Ultrasensitive chemiluminescent detection of plasma Aβ1-40 based on soluble macromolecular signal amplification carrier | |
| JP2017526924A5 (enExample) | ||
| EP4619033A1 (en) | Novel biomarker and target for treating pulmonary hypertension |